A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

Patients with chronic kidney disease and those on dialysis have chronic pain and want to talk about it with their ...

Use of glucagon-like peptide-1 receptor agonists might be beneficial for patients with some cancers, research suggests.